menu search

Iovance (iova) down after announcing data from melanoma study

Results from a cohort of the phase ii study evaluating Iovance's (IOVA) melanoma candidate were not as ...

May 27, 2022, 3:49 pm

4d pharma outlines phase ii plans for promising cancer drug candidate

4D pharma PLC (AIM:DDDD, NASDAQ:LBPS) will deliver what's called a ‘trial in progress' poster at a world-leading cancer conference outlining the pla...

May 27, 2022, 2:50 am

Tokio marine holdings, inc. (tkomy) ceo satoru komiya on h1 fy2022 - ir conference call transcript

Tokio Marine Holdings, Inc. (OTCPK:TKOMY) H1 2022 Earnings Conference Call May 26, 2022 3:00 AM ET Company Participants Satoru Komiya - President and ...

May 27, 2022, 12:01 am

Aerie (aeri) starts late-stage study to treat dry eye disease

Aerie Pharmaceutials (AERI) doses the first patient in a phase iiI study on its investigational TRMP8 a...

May 25, 2022, 4:03 pm

Hawaiian holdings (ha) loses 41.7% in a year: what's ailing it?

Elevated operating cost and higher fuel prices hurt Hawaiian Holdings' (HA)....

May 25, 2022, 4:03 pm

Springworks (swtx) down despite desmoid tumors study meeting goal

SpringWorks' (SWTX) phase iiI study evaluating its investigational candidate, nirogacestat, in adult pa...

May 25, 2022, 1:48 pm

Salem media group to present at the ld micro invitational xii

IRVING, Texas--(BUSINESS WIRE)--Salem Media Group to Present at the LD Micro Invitational Xii...

May 25, 2022, 12:00 pm

Immupharma says it is in talks with partners for key assets as it hails progress made last year

ImmuPharma PLC (AIM:IMM, OTC:IMMPF) hailed its recent progress as it said major roadblocks to clinical progress had been effectively cleared. In an ...

May 25, 2022, 2:48 am

J.p. morgan chase stock bounces off 18-month low after raising nii outlook

Shares of J.P. Morgan Chase & Co. JPM, -0.82% rallied 1.7% in premarket trading Monday, to bounce off an 18-month low in the previous session, after t...

May 23, 2022, 8:57 am

Centennial and colgate energy partners enter merger of equals agreement

Centennial Resource Development Inc. (NASDAQ: CDEV) has announced a merge of equals agreement with Colgate Energy Partners ...

May 20, 2022, 11:10 pm

Blue star foods to present at two upcoming investor conferences

CEO John Keeler to Present and Host Meetings at H.C. Wainwright Global Investment Conference and LD Micro Invitational X...

May 20, 2022, 8:30 am

Irwin naturals licenses its brand to colorado manufacturer of cannabis products larsen group ii

Irwin Naturals Inc. (CSE:IWIN) said it has licensed its brand to Larsen Group ii LLC, a Colorado manufa...

May 20, 2022, 8:09 am

Mgc pharmaceuticals' artemic oral spray “bears great promise for covid-19 patients”, says peer-reviewed scientific paper

MGC Pharmaceuticals Ltd (LSE:MXC, OTC:MGCLF, ASX:MXC)'s ArtemiC oral spray “bears great promise for COVID-19 patients”, according to a peer-review...

May 20, 2022, 3:36 am

Aecom is a good long-term bet

AECOM reported strong order and backlog growth in the last quarter. The Omnibus appropriation bill passed in March and the ...

May 19, 2022, 11:23 am

Horizon (hznp) begins enrollment in alopecia areata study

Horizon (HZNP) enrolls the first patient in a phase ii study evaluating daxdilimab (HZN-7734) for the t...

May 18, 2022, 12:47 pm

Cardiol therapeutics receives us fda authorization for phase ii study of cardiolrx for recurrent pericarditis

Cardiol Therapeutics (TSX:CRDL, NASDAQ:CRDL) Inc announced that the US Food and Drug Administration has authorized its Investigational New Drug Applic...

May 17, 2022, 10:07 am

The greatest reit wannabes of all time: part ii

Many of you are familiar with the "CCC" list that includes the champions, contenders, and challengers. We look favorably on companies that can increas...

May 17, 2022, 7:00 am

4d pharma conference poster underlines safety and potential efficacy of asthma drug candidate

4D pharma PLC (AIM:DDDD, NASDAQ:LBPS) said it will present an update from the phase I/ii trial of its p...

May 17, 2022, 2:29 am

Taysha gene therapies, inc. (tsha) ceo ra session ii on q1 2022 results - earnings call transcript

Taysha Gene Therapies, Inc. (NASDAQ:TSHA ) Q1 2022 Earnings Conference Call May 16, 2022 8:00 AM ET Company Participants Kimberly Lee - Chief Corporat...

May 16, 2022, 2:47 pm

Kddi corporation (kddiy) management on q4 2022 results - earnings call transcript

KDDI Corporation (OTCPK:KDDIY) Q4 2022 Earnings Conference Call May 13, 2022 4:30 AM ET Company Participants Ikuko Hongou - General Manager, Investor ...

May 16, 2022, 2:42 pm


Search within

Pages Search Results: